Shimabukuro Michio, Higa Namio, Masuzaki Hiroaki, Sata Masataka, Ueda Shinichiro
Department of Cardio-Diabetes Medicine, Institute of Biomedical Sciences, Tokushima University Graduate School, 3-18-15 Kuramoto, Tokushima, 770-8503, Japan.
Cardiovascular Department, Naha City Hospital, Okinawa, Japan.
Cardiovasc Diabetol. 2016 May 17;15:77. doi: 10.1186/s12933-016-0394-5.
Impaired vasoreactivity is often observed in subjects with metabolic syndrome, a condition that includes the presence of a specific cluster of risk factors for obesity and cardiovascular disease. However, hierarchical causes in the impaired vasoreactivity have not been clarified. We evaluated the impact of individual metabolic risk components or its clustering under the condition of insulin resistance on endothelial and smooth muscle cell function.
Vascular reactivity to acetylcholine (Ach), with or without nitric oxide synthase (NOS) inhibitor N (G)-monomethyl-L-arginine (L-NMMA), or sodium nitroprusside (SNP) by forearm venous occlusion plethysmography and insulin sensitivity index (M mg/kg/min) in euglycemic clamp were measured in men without (n = 18, control group) or with (n = 19, metabolic syndrome group) metabolic syndrome.
(1) Ach-induced maximal forearm blood flow (maxFBF) was impaired in subjects with metabolic syndrome. In particular, the NOS-dependent component of Ach-induced maxFBF was selectively decreased, while the NOS-independent component remained relatively unchanged. (2) Ach-induced maxFBF and ∆Ach-induced maxFBF with L-NMMA were correlated with waist circumference, glucose, and triglycerides, and most strongly correlated with visceral fat area, adiponectin, and M. (3) Multivariate regression analysis indicated that individual metabolic risk components explained Ach-induced maxFBF by 4-21 %. Clustering of all metabolic risk components increased this to 35 %, and the presence of metabolic syndrome explained 30 %, indicating that defining metabolic syndrome can effectively predict impairment of endothelial dysfunction.
Endothelial dysfunction was correlated with individual metabolic risk components, but more strongly with clustering of the components under a condition with low insulin sensitivity. We suggest that in subjects with metabolic syndrome, endothelial function is impaired by multiple cardiovascular risk factors exclusively when under the condition of insulin insensitivity and also that defining metabolic syndrome can effectively predict impairment of endothelial dysfunction.
血管反应性受损在代谢综合征患者中经常被观察到,代谢综合征是一种包含肥胖和心血管疾病特定风险因素集群的病症。然而,血管反应性受损的层级原因尚未明确。我们评估了在胰岛素抵抗情况下个体代谢风险成分或其聚类对内皮细胞和平滑肌细胞功能的影响。
通过前臂静脉闭塞体积描记法测量对乙酰胆碱(Ach)、有或无一氧化氮合酶(NOS)抑制剂N(G)-单甲基-L-精氨酸(L-NMMA)或硝普钠(SNP)的血管反应性,并且在正常血糖钳夹试验中测量胰岛素敏感性指数(M mg/kg/min),研究对象为无(n = 18,对照组)或有(n = 19,代谢综合征组)代谢综合征的男性。
(1)代谢综合征患者中Ach诱导的最大前臂血流量(maxFBF)受损。特别是,Ach诱导的maxFBF的NOS依赖性成分选择性降低,而NOS非依赖性成分保持相对不变。(2)Ach诱导的maxFBF以及使用L-NMMA时∆Ach诱导的maxFBF与腰围、血糖和甘油三酯相关,并且与内脏脂肪面积、脂联素和M的相关性最强。(3)多变量回归分析表明,个体代谢风险成分解释了Ach诱导的maxFBF的4 - 21%。所有代谢风险成分的聚类将这一比例提高到35%,代谢综合征的存在解释了30%,表明定义代谢综合征可以有效预测内皮功能障碍的损害。
内皮功能障碍与个体代谢风险成分相关,但在胰岛素敏感性较低的情况下,与这些成分的聚类相关性更强。我们认为,在代谢综合征患者中,仅在胰岛素不敏感的情况下,内皮功能会受到多种心血管风险因素的损害,并且定义代谢综合征可以有效预测内皮功能障碍的损害。